ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Sunshine Biopharma Inc

Sunshine Biopharma Inc (SBFM)

0.2731
0.004
( 1.49% )
更新日時: 23:15:28

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
0.2731
買値
0.27
売値
0.2732
出来高
119,633
0.2667 日の範囲 0.2789
0.2655 52 週間の範囲 64.50
時価総額
前日終値
0.2691
始値
0.2711
最終取引時間
23:15:08
財務取引量
US$ 32,524
VWAP
0.271866
平均取引量 (3 か月)
2,551,789
発行済株式数
18,945,052
配当利回り
-
PER
-1.14
1 株当たり利益 (EPS)
-0.24
歳入
24.09M
純利益
-4.51M

Sunshine Biopharma Inc について

Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of ... Sunshine Biopharma Inc is a pharmaceutical company focused on the research, development, and commercialization of oncology and antiviral drugs. In addition, it is engaged in the development and commercialization of science-based nutritional supplements. The company is focusing on the development of the licensed Adva-27a anticancer drug, a small molecule that has been shown to be exceptionally effective at destroying Multidrug-Resistant Cancer Cells, including Pancreatic Cancer cells (Panc-1), Small-Cell Lung Cancer cells (H69AR), Breast Cancer cells (MCF-7/MDR) and Uterine Sarcoma cells (MES-SA/Dx5). 詳細を表示

セクター
Coml Physical, Biologcl Resh
業界
Coml Physical, Biologcl Resh
ウェブサイト
本社
Montreal, Quebec, Can
設立
1970
Sunshine Biopharma Inc is listed in the Coml Physical, Biologcl Resh sector of the ナスダック市場 with ticker SBFM. The last closing price for Sunshine Biopharma was US$0.27. Over the last year, Sunshine Biopharma shares have traded in a share price range of US$ 0.2655 to US$ 64.50.

Sunshine Biopharma currently has 18,945,052 shares in issue. The market capitalisation of Sunshine Biopharma is US$5.10 million. Sunshine Biopharma has a price to earnings ratio (PE ratio) of -1.14.

SBFM 最新ニュース

MGM Reliance On Sports Betting Could Bode Well For WNRS

August 13, 2021 -- InvestorsHub NewsWire -- via pennymillions In a recent Investor’s Business Daily report on MGM Resorts International (MGM), MGM’s BetMGM’s...

MedX Holdings, Inc. Announces OTC "Current" Status

    MedX Holdings, Inc. Announces OTC "Current" Status   Cheyenne, WY -- November 3, 2020 -- InvestorsHub NewsWire -- MedX Holdings Inc. (OTC PINK:...

MedX Holdings, Inc. is proud to announce its new CEO and President

 MedX Holdings, Inc. is proud to announce its new CEO and President    Cheyenne, WY -- September 28, 2020 -- InvestorsHub NewsWire -- MedX Holdings, Inc. (OTC...

MedX Holdings, Inc. (MEDH) Enters the Legalized Marijuana Industry in California through Licensing and Lease Agreement

CHEYENNE, Wyo., April 26, 2018 (GLOBE NEWSWIRE) -- MedX Holdings, Inc. (OTC Pink:MEDH) has completed the licensing and lease agreements to a Humboldt County, CA marijuana grow operation.  In...

MedX Holdings, Inc. Gives A Timely Market Update

CHEYENNE, Wyo., July 12, 2016 (GLOBE NEWSWIRE) -- MedX Holdings, Inc. (OTC PINK:MEDH) in keeping with our promise to be completely transparent with our investors we want to discuss why...

Volume has been starting to build with this stock

MEDH Is Our Newest LOW FLOAT Breakout Play! This Stock May Not Remain Under The Radar Much Longer!   Greetings Traders, We have another top potential trading opportunity for you...

MedQuist Holdings Becomes M*Modal

MedQuist Holdings (NASDAQ/GS: MEDH), a leading provider of integrated clinical documentation solutions for the U.S. healthcare system, today announced the unification of the...

MedQuist Holdings Hires Amy Dellamora Amick as Operations Leader

MedQuist Holdings Inc. (NASDAQ/GS: MEDH), a leading provider of integrated clinical documentation solutions for the U.S. healthcare system, announced today that Amy Dellamora...

MedQuist Holdings to Report 2011 Results Consistent with Previous Performance Goals

MedQuist Holdings Inc. (NASDAQ/GS: MEDH), a leading provider of integrated clinical documentation solutions for the U.S. healthcare system, announced it expects to report...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
1-0.0221-7.48644986450.29520.30970.26557375150.28757965CS
4-0.0469-14.656250.320.37980.26558077410.32111429CS
12-0.6572-70.64387831880.93031.160.265525517890.53881653CS
26-25.2269-98.929019607825.526.990.2655140496217.20199896CS
52-50.7269-99.46450980395164.50.265570508357.53182086CS
156-274.7269-99.90069090912759870.26554403518159.70006028CS
260-274.7269-99.90069090912759870.26554403518159.70006028CS

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
BBLGBone Biologics Corporation
US$ 3.275
(51.62%)
51.57M
RDHLRedhill Biopharma Ltd
US$ 0.5735
(49.31%)
153.09M
IMRXImmuneering Corporation
US$ 1.5699
(38.93%)
50.7M
BMEABiomea Fusion Inc
US$ 7.24
(29.98%)
2.47M
OMCLOmnicell Inc
US$ 35.45
(21.36%)
375.18k
VWEVintage Wine Estates Inc
US$ 0.032
(-38.34%)
15.5M
ALXOALX Oncology Holdings Inc
US$ 3.255
(-32.19%)
3.75M
LABStandard BioTools Inc
US$ 1.565
(-30.13%)
2.03M
ATECAlphatec Holdings Inc
US$ 7.41
(-26.63%)
4.19M
NCNCnoco noco Inc
US$ 0.2194
(-23.55%)
5.27M
RDHLRedhill Biopharma Ltd
US$ 0.5735
(49.31%)
153.09M
NVDANVIDIA Corporation
US$ 118.0101
(0.85%)
93.83M
HUGEFSD Pharma Inc
US$ 0.1097
(8.61%)
65.12M
BBLGBone Biologics Corporation
US$ 3.275
(51.62%)
51.57M
IMRXImmuneering Corporation
US$ 1.5699
(38.93%)
50.7M

SBFM Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock